Polycomponent Ophthalmic Inserts with Polysaccharide Support
- 1 October 1988
- journal article
- Published by SAGE Publications in Journal of Bioactive and Compatible Polymers
- Vol. 3 (4) , 370-389
- https://doi.org/10.1177/088391158800300404
Abstract
Ophthalmic inserts, based on xanthane modified with pilocarpine, adrena line and hydrocortisone have been prepared. The drugs were fixed in the insert by ionic bonds and gel entrapment. The in vitro release rate of pilocarpine de pended on the degree of xanthane modification and on the drug content in the polymer matrix. Inserts show a high ophthalmic tolerance indicating the potential for treatment of glaucoma.Keywords
This publication has 7 references indexed in Scilit:
- Bioactive polymers XXXIX. Retarded ophthalmic drugs base on pilocarpine and xanthan derivativesClinical Materials, 1987
- Polymeric Inserts for Sustained Ocular Delivery of PilocarpinePublished by Springer Nature ,1986
- Vehicle effects in ophthalmic bioavailability: An evaluation of polymeric inserts containing pilocarpineJournal of Pharmacy and Pharmacology, 1984
- A Soluble Sustained-Release Ophthalmic Delivery UnitAmerican Journal of Ophthalmology, 1977
- ANTIMICROBIAL TREATMENT OF CHRONIC BRONCHITISThe Lancet, 1975
- Ocular Penetration of Pilocarpine in PrimatesAmerican Journal of Ophthalmology, 1973
- Optimal Ferric Hydroxamate Method for Determination of Intact PilocarpineJournal of Pharmaceutical Sciences, 1970